Full Description
The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.New in the 26th edition:First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactamReplacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infectionsUpdates on management of influenza, including baloxavir (now approved for children >12 years)New approaches to treatment of mucomycosisNew recommendations for malariaMore than 150 new references!
Contents
Notable Changes to 2020 Nelson's Pediatric Antimicrobial Therapy, 26th Edition1. Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones2. Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins3. How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes4. Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus5. Antimicrobial Therapy for Newborns A. Recommended Therapy for Selected Newborn ConditionsB. Antimicrobial Dosages for NeonatesC. AminoglycosidesD. VancomycinE. Use of Antimicrobials During Pregnancy or Breastfeeding6. Antimicrobial Therapy According to Clinical Syndromes A. Skin and Soft Tissue InfectionsB. Skeletal InfectionsC. Eye InfectionsD. Ear and Sinus InfectionsE. Oropharyngeal InfectionsF. Lower Respiratory Tract InfectionsG. Cardiovascular InfectionsH. Gastrointestinal InfectionsI. Genital and Sexually Transmitted InfectionsJ. Central Nervous System InfectionsK. Urinary Tract InfectionsL. Miscellaneous Systemic Infections7. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens A. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)B. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)C. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)D. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens8. Preferred Therapy for Specific Fungal Pathogens A. Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal SusceptibilitiesB. Systemic InfectionsC. Localized Mucocutaneous Infections9. Preferred Therapy for Specific Viral Pathogens A. Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to AntiviralsB. Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to AntiviralsC. Preferred Therapy for Specific Viral Pathogens10. Preferred Therapy for Specific Parasitic Pathogens A. Selected Common Pathogenic Parasites and Suggested Agents for TreatmentB. Preferred Therapy for Specific Parasitic Pathogens11. Alphabetic Listing of Antimicrobials A. Systemic Antimicrobials With Dosage Forms and Usual DosagesB. Topical Antimicrobials (Skin, Eye, Ear, Mucosa)12. Antibiotic Therapy for Children Who Are Obese13. Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections14. Antimicrobial Prophylaxis/Prevention of Symptomatic Infection A. Postexposure Antimicrobial Prophylaxis to Prevent InfectionB. Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New InfectionC. Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent InfectionD. Surgical/Procedure ProphylaxisAppendix: Nomogram for Determining Body Surface AreaReferencesIndex
